Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
about
Management of HBV Infection in Liver Transplantation PatientsCharacterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formationEntecavir-Associated Thrombocytopenia in a Decompensated Cirrhotic Patient: A Case Report and Literature ReviewThe Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsThe Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis BThe importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysisDirect acting antivirals for the treatment of chronic viral hepatitisClinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.Prophylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.A case of anti-GBM glomerulonephritis superimposed on HBV-associated membranous nephropathyEarly viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis BA simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effectiveApplication of hepatitis B virus replication mouse modelEvaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNAInhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formationEntecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.The role of entecavir in the treatment of chronic hepatitis B.Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.Inhibition of hepatitis B virus surface antigen expression by small hairpin RNA in vitro.Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomesEntecavir: a potent new antiviral drug for hepatitis B.Slowing the progression of chronic hepatitis B. Early antiviral therapy can help minimize complications.Agents in clinical development for the treatment of chronic hepatitis B.Emerging drugs for hepatitis B.Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.New aspects on the natural history of chronic hepatitis B infection: implication for therapy.Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.Antivirals and antiviral strategies.Emerging treatments in chronic hepatitis B.Review article: Nucleoside analogues for the treatment of chronic hepatitis B.Molecular virology of hepatitis B virus for clinicians.Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.Complications in treating chronic hepatitis B in patients with HIV.Management of chronic hepatitis B virus infection: a new era of disease control.Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in ChinaEntecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.
P2860
Q24529103-DDC2CECA-AC31-401D-816E-3F233253ABD8Q24681546-25A83728-D70C-489D-9D9D-F3CC94F9D54CQ26750766-94BAC45E-4303-41F2-977B-D0CAEEB6F190Q26781795-E459F6C7-36E9-4D17-9001-EA97931F622FQ27007019-FE79165D-E3D7-4B07-B5F7-6D1BEB0C90BAQ27016075-28D720DF-A707-457F-9567-30A2BF51F726Q27022216-769E8634-9B85-461E-A9D7-B522014B3386Q33206221-47D23AC4-6608-4472-9E96-D8D3DB2D3C5EQ33207885-953E7882-6C9D-47FE-A92C-19EAA9F42796Q33492413-99F191C6-6988-4842-98CE-412E01382611Q33508709-6D2D701B-9BD4-4AB5-8EFA-2B99B978D0D2Q33622153-B607FC9F-C92D-449B-A7F5-C35D5614C43FQ33676349-9A3EAC57-4A5E-4F5C-9AB6-7F56F6B24BA3Q33804151-E14B2419-7304-4AEB-84AF-CE9E48827827Q33812160-45A10712-3FA8-4491-844A-F3E282C64CC7Q33825842-F854BE80-CFDC-4675-BE37-EF1619D3C074Q33869291-738D1481-B214-456B-9350-8A147674ED23Q34389487-AE526C48-BF03-4669-B4A3-1B53F444DDF6Q34584406-84DFBC69-7820-4B88-8BA2-14760C3F6BE4Q34592640-99430179-9BB7-41B4-81A5-5F838E85D412Q34594403-32F5BCA0-F884-47E9-89BF-A4B8815CB3C9Q34605719-80BB0692-9565-4C43-A1CC-64AF3B4AA6A7Q34998226-4C1E7079-DDFD-4141-8C45-37D2DDAFE633Q35094702-7D1A0124-C34C-43CD-A062-566DC094BDA6Q35182686-079E5C1C-16A5-4902-84DC-DD7F174FA57CQ35185749-FF4D03A2-C592-46F0-ADE5-31427FC95D15Q35359369-BA943E23-4F63-423D-BC19-9DE4BF93FC0FQ35597930-B1465A9C-89FB-4A68-BD22-345C9877A515Q35628953-212FBA8F-107B-4F89-B8F7-B84F857E2C0AQ35635844-EF8FA6D9-F8A3-4C60-9FB3-EB569A3CFBFAQ35889586-5D6A12EB-68F8-47AF-955A-FCBA116D5029Q35967369-67C41447-E36C-456D-A3E3-532AF238BEA7Q35987869-E1EA0BD5-48F8-4E46-9746-294613F8FED5Q36282234-C247579D-AFDC-4523-AC8A-18A969EDBEF0Q36304057-6A0D56BF-F209-4F5C-A2B4-999BCE8C7E09Q36327100-74EB48D9-C5C4-47DB-84CF-E1D84EC14143Q36393856-D8DCD5A7-B095-4646-A657-5BA9C8742C7EQ36573919-A7353C6E-69F5-4F4C-86B9-DAADF8CD28F1Q37278075-8FB537FC-8CB3-4BFA-B8E5-9173D6ABAC36Q37291331-2952D12C-D856-46FF-9BC7-14498DAD9978
P2860
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Entecavir is superior to lamiv ...... chronic hepatitis B infection.
@en
Entecavir is superior to lamiv ...... chronic hepatitis B infection.
@nl
type
label
Entecavir is superior to lamiv ...... chronic hepatitis B infection.
@en
Entecavir is superior to lamiv ...... chronic hepatitis B infection.
@nl
prefLabel
Entecavir is superior to lamiv ...... chronic hepatitis B infection.
@en
Entecavir is superior to lamiv ...... chronic hepatitis B infection.
@nl
P2093
P356
P1433
P1476
Entecavir is superior to lamiv ...... chronic hepatitis B infection
@en
P2093
Deborah Dehertogh
Frank H Anderson
Hans Van Vlierberghe
Mohamed Rosmawati
Neal Thomas
P304
P356
10.1053/GAST.2002.37058
P407
P577
2002-12-01T00:00:00Z